← Leaderboards
Gary R Whittaker
Cornell University Ithaca
$7,783,654
Attributed
$9,268,808
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $849.3K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,268,808 · 10
By mechanism
R01$5,891,414 · 2
R21$2,742,248 · 6
R56$477,146 · 1
R03$158,000 · 1
Top collaborators
- Susan Daniel7 shared
- Hector Aguilar-Carreno1 shared
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsVirusViralCellsLeadMediatingInfectionEventBasePeptide HydrolasesRouteReceptorPathogenCoronavirusFlexibilityBiochemicalInnovationCell TypeCell SurfaceDisease OutbreaksMembrane FusionMiddle East Respiratory Syndrome CoronavirusEndosomesCommunicable Diseases
Grant awards (32)
Developing broad-based treatments for respiratory viruses by targeting host cell TTSPs$477,146
R56 · FY2024 · AI · contact PI
Broad-based spike protein stalk-based vaccine platform for SARS-CoV-2 and other coronaviruses$235,500
R21 · FY2022 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$439,686
R01 · FY2021 · AI · contact PI
Broad-based spike protein stalk-based vaccine platform for SARS-CoV-2 and other coronaviruses$196,250
R21 · FY2021 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$174,298
R01 · FY2021 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$532,013
R01 · FY2020 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$229,985
R01 · FY2020 · AI · contact PI
Structural and Functional Analysis of the Coronavirus Spike Protein Fusion Peptide$87,264
R01 · FY2020 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$523,463
R01 · FY2019 · AI · contact PI
Development of a subunit vaccine for MERS-CoV and other emerging coronaviruses$235,500
R21 · FY2019 · AI · contact PI
Structural and functional analysis of the coronavirus spike protein fusion peptide$506,453
R01 · FY2018 · AI · contact PI
Development of a subunit vaccine for MERS-CoV and other emerging coronaviruses$196,146
R21 · FY2018 · AI · contact PI
Development of novel protease inhibitors for influenza and paramyxoviruses$234,875
R21 · FY2017 · AI · contact PI
Development of novel protease inhibitors for influenza and paramyxoviruses$221,875
R21 · FY2016 · AI · contact PI
Spike protein cleavage-activation and emergence of coronaviruses with extended tr$227,554
R21 · FY2015 · AI · contact PI
Spike protein cleavage-activation and emergence of coronaviruses with extended tr$191,349
R21 · FY2014 · AI · contact PI
Endocytosis of Influenza Viruses$363,257
R01 · FY2011 · AI · contact PI
Endocytosis of Influenza Viruses$367,130
R01 · FY2010 · AI · contact PI
Priming and fusion activation of the SARS coronavirus spike glycoprotein$190,575
R21 · FY2010 · AI · contact PI
Endocytosis of Influenza Viruses$371,038
R01 · FY2009 · AI · contact PI
Priming and fusion activation of the SARS coronavirus spike glycoprotein$192,500
R21 · FY2009 · AI · contact PI
Endocytosis of Influenza Viruses$371,231
R01 · FY2008 · AI · contact PI
Endocytosis of Influenza Viruses$377,422
R01 · FY2007 · AI · contact PI
Receptor utilization for influenza virus entry in vivo$309,974
R21 · FY2006 · AI · contact PI
Endocytosis of Influenza Viruses$313,004
R01 · FY2005 · AI
Receptor utilization for influenza virus entry in vivo$310,150
R21 · FY2005 · AI
Entry of Coronaviruses into Host Cells$79,000
R03 · FY2005 · AI
Endocytosis of Influenza Viruses$313,150
R01 · FY2004 · AI
Entry of Coronaviruses into Host Cells$79,000
R03 · FY2004 · AI
Endocytosis of Influenza Viruses$313,291
R01 · FY2003 · AI
Endocytosis of Influenza Viruses$313,428
R01 · FY2002 · AI
Endocytosis of Influenza Viruses$295,301
R01 · FY2001 · AI